TR200000135T2 - Tiazolidinedion ve sülfonilüre ile diabet tedavisi. - Google Patents

Tiazolidinedion ve sülfonilüre ile diabet tedavisi.

Info

Publication number
TR200000135T2
TR200000135T2 TR2000/00135T TR200000135T TR200000135T2 TR 200000135 T2 TR200000135 T2 TR 200000135T2 TR 2000/00135 T TR2000/00135 T TR 2000/00135T TR 200000135 T TR200000135 T TR 200000135T TR 200000135 T2 TR200000135 T2 TR 200000135T2
Authority
TR
Turkey
Prior art keywords
thiazolidinedione
sulfonylurea
diabetes treatment
mammal
mellitus
Prior art date
Application number
TR2000/00135T
Other languages
English (en)
Inventor
Edwin Buckingham Robin
Alistair Smith Stephen
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200000135(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200000135T2 publication Critical patent/TR200000135T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Etkili, toksik olmayan ve eczacilik teknolojisi bakimindan kabul edilebilir tutarda bir ensülin yönünden duyarli duruma getiricinin, maksimum altinda miktarda bir insülin salgilattiricisinin, bunlara gereksinmesi bulunan bir memeliye verilmesini içeren diabetas mellitus' un memelide diabetes mellitus ile iliskili durumlarin tedavi edilmeleri için yöntem ile bu gibi yöntemin kullanilmasina yarar bilesim.
TR2000/00135T 1997-07-18 1998-07-16 Tiazolidinedion ve sülfonilüre ile diabet tedavisi. TR200000135T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200000135T2 true TR200000135T2 (tr) 2000-05-22

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00135T TR200000135T2 (tr) 1997-07-18 1998-07-16 Tiazolidinedion ve sülfonilüre ile diabet tedavisi.

Country Status (40)

Country Link
EP (1) EP0998291B2 (tr)
JP (2) JP2001510158A (tr)
KR (1) KR100680667B1 (tr)
CN (1) CN1264302A (tr)
AP (1) AP1318A (tr)
AR (2) AR016768A1 (tr)
AT (1) ATE366577T1 (tr)
AU (1) AU743269B2 (tr)
BG (1) BG64892B1 (tr)
BR (1) BR9810904A (tr)
CA (1) CA2297115C (tr)
CO (1) CO4940422A1 (tr)
CY (1) CY1107745T1 (tr)
CZ (1) CZ302668B6 (tr)
DE (1) DE69838066T3 (tr)
DK (1) DK0998291T4 (tr)
DZ (1) DZ2564A1 (tr)
EA (1) EA003303B1 (tr)
ES (1) ES2290989T5 (tr)
GB (1) GB9715306D0 (tr)
HU (1) HU229119B1 (tr)
ID (1) ID24198A (tr)
IL (1) IL134045A0 (tr)
IN (1) IN189035B (tr)
MA (1) MA26522A1 (tr)
MY (1) MY138246A (tr)
NO (1) NO326356B1 (tr)
NZ (3) NZ520652A (tr)
OA (1) OA11632A (tr)
PE (1) PE99799A1 (tr)
PL (2) PL199125B1 (tr)
PT (1) PT998291E (tr)
SI (1) SI0998291T2 (tr)
SK (2) SK288053B6 (tr)
TR (1) TR200000135T2 (tr)
TW (1) TW586926B (tr)
UA (1) UA70302C2 (tr)
UY (1) UY25103A1 (tr)
WO (1) WO1999003476A1 (tr)
ZA (1) ZA986365B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
ATE508738T1 (de) 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln
MXPA06004639A (es) * 2003-10-31 2006-06-27 Takeda Pharmaceutical Preparacion solida que comprende sensibilizador de insulina, secretagogo de insulina y ester de acidos grasos de polioxietileno sorbitano.
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
ZA200805147B (en) 2005-12-22 2010-05-26 Takeda Pharmaceutical Solid preparation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
EP0528764B1 (en) * 1991-08-16 1996-06-12 Sandoz Ltd. Inhaler for administration of powdery substances
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
BG104139A (en) 2000-11-30
JP2005247865A (ja) 2005-09-15
EP0998291A1 (en) 2000-05-10
NZ520652A (en) 2004-06-25
NO20000229D0 (no) 2000-01-17
UY25103A1 (es) 2000-12-29
KR20010021948A (ko) 2001-03-15
TW586926B (en) 2004-05-11
DE69838066D1 (de) 2007-08-23
CO4940422A1 (es) 2000-07-24
EP0998291B1 (en) 2007-07-11
IL134045A0 (en) 2001-04-30
ATE366577T1 (de) 2007-08-15
PT998291E (pt) 2007-10-11
AP2000001734A0 (en) 2000-03-31
NO20000229L (no) 2000-01-17
EA200000141A1 (ru) 2000-08-28
CA2297115A1 (en) 1999-01-28
HU229119B1 (en) 2013-08-28
JP2001510158A (ja) 2001-07-31
NO326356B1 (no) 2008-11-17
PL199125B1 (pl) 2008-08-29
HK1029272A1 (en) 2001-03-30
SK602000A3 (en) 2000-07-11
PL338127A1 (en) 2000-09-25
KR100680667B1 (ko) 2007-02-09
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
ES2290989T5 (es) 2011-11-11
HUP0003634A2 (hu) 2001-07-30
SI0998291T2 (sl) 2011-10-28
GB9715306D0 (en) 1997-09-24
SK288053B6 (sk) 2013-03-01
AU8448798A (en) 1999-02-10
NZ501256A (en) 2002-09-27
SK287823B6 (sk) 2011-11-04
BG64892B1 (bg) 2006-08-31
DZ2564A1 (fr) 2003-02-15
AP1318A (en) 2004-10-22
CN1264302A (zh) 2000-08-23
EP0998291B2 (en) 2011-07-06
HUP0003634A3 (en) 2003-04-28
AU743269B2 (en) 2002-01-24
AR016768A1 (es) 2001-08-01
DK0998291T4 (da) 2011-09-26
WO1999003476A1 (en) 1999-01-28
BR9810904A (pt) 2000-09-26
CZ302668B6 (cs) 2011-08-24
SI0998291T1 (sl) 2007-12-31
NZ515555A (en) 2002-09-27
CZ2000173A3 (en) 2001-05-16
AR019331A2 (es) 2002-02-13
CY1107745T1 (el) 2013-04-18
ES2290989T3 (es) 2008-02-16
IN189035B (tr) 2002-12-07
UA70302C2 (uk) 2004-10-15
DK0998291T3 (da) 2007-11-05
MA26522A1 (fr) 2004-12-20
MY138246A (en) 2009-05-29
DE69838066T3 (de) 2012-03-29
PE99799A1 (es) 1999-12-22
CA2297115C (en) 2010-02-23
OA11632A (en) 2004-11-22
ID24198A (id) 2000-07-13
ZA986365B (en) 2000-01-17

Similar Documents

Publication Publication Date Title
TR200000134T2 (tr) Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.
TR199903057T2 (tr) Diabetin tiazolidinedion ve metformin ile tedavisi.
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
TR200100600T2 (tr) İnsülinotropik peptitlerin kullanımı.
NO940436L (no) Forlenget avgivelse av peptider
TR200100079T2 (tr) Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1
DE69327309D1 (de) Verwendung eines peptids
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
ATE193541T1 (de) Insulinotropes hormon
BR9106977A (pt) Metodo para suprimir destruicao autoimune de celuias beta pancreaticas,formulacao farmaceutica,metodo de profilaxia,metodo para prevenir o surgimento de diabetes tipo 1 e metodo para tratar um mamifero
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
DK1294757T3 (da) Glucagonlignende peptid 1-analoger
TR200000135T2 (tr) Tiazolidinedion ve sülfonilüre ile diabet tedavisi.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
TR200000133T2 (tr) Tiazolidinedion, ensülin salgılattırıcısı ve alfa glükosidaz inhibitörü ile diabetin (şeker hastasının) tedavisi.
TR199903096T2 (tr) Diabetin tiazolidinedion ve sülfonilüre ile tedavisi.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
BR9810186A (pt) Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
EP1173186A4 (en) USE OF TAGATOSIS TO INCREASE KEY BLOOD FACTORS
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
IL143088A0 (en) A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method
ECSP982593A (es) Nuevo metodo de tratamiento vi
ECSP982542A (es) Nuevo metodo de tratamiento iii